Rifabutin [clinicaltrials_resource:0873c60740b3276b384569eae4aec237]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00107536 [clinicaltrials_resource:273f28a85c6566d76ff76854cd53b9fb]eligibility for clinicaltrials:NCT00134069 [clinicaltrials_resource:31c44eb02996a6c0ff1a0b62791f3b16]eligibility for clinicaltrials:NCT00118157 [clinicaltrials_resource:38c27da684633d4e18d079b4d14c3854]eligibility for clinicaltrials:NCT00397787 [clinicaltrials_resource:44f7445b33573724f39d2c3350c2edd2]eligibility for clinicaltrials:NCT00617708 [clinicaltrials_resource:5779b97f6e8f19f4261bc4fbf6ffca8f]eligibility for clinicaltrials:NCT00378911 [clinicaltrials_resource:90e2573b962fa7b00d8bc3d81c673d4b]eligibility for clinicaltrials:NCT00096499 [clinicaltrials_resource:a07408bbc65c5b2266e419ce0526be68]eligibility for clinicaltrials:NCT00906360 [clinicaltrials_resource:ab102d1f180ab3114d9eef4e4cd8cffd]eligibility for clinicaltrials:NCT00387920 [clinicaltrials_resource:ae648621e7eda92397728786d3a31e65]eligibility for clinicaltrials:NCT00398112 [clinicaltrials_resource:baa879f991df91a619bf63a4eb76ddf8]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites [clinicaltrials:NCT00000826]Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults [clinicaltrials:NCT00000877]The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients [clinicaltrials:NCT00001023]The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [clinicaltrials:NCT00001030]Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [clinicaltrials:NCT00001047]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00001995]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002032]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [clinicaltrials:NCT00002080]A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [clinicaltrials:NCT00002101]A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients [clinicaltrials:NCT00002122]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002267]A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00002343]Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [clinicaltrials:NCT00004736]Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [clinicaltrials:NCT00018083]TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [clinicaltrials:NCT00023348]TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [clinicaltrials:NCT00023361]TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [clinicaltrials:NCT00023400]TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [clinicaltrials:NCT00023413]Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis [clinicaltrials:NCT00513552]Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease [clinicaltrials:NCT00598897]Use of Azithromycin and Rifabutin Administered Three Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease [clinicaltrials:NCT00598962]Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa [clinicaltrials:NCT00640887]clinicaltrials:NCT00646776Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam [clinicaltrials:NCT00651066]A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects [clinicaltrials:NCT00743470]Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients [clinicaltrials:NCT00810407]Safety And Efficacy Of Rifabutin In HIV Patients [clinicaltrials:NCT00810446]clinicaltrials:NCT00869518Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [clinicaltrials:NCT00877591]Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061) [clinicaltrials:NCT00925535]Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers [clinicaltrials:NCT01231542]clinicaltrials:NCT01259219TMC207 +/- Rifabutin/Rifampin [clinicaltrials:NCT01341184]Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV [clinicaltrials:NCT01601626]A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants [clinicaltrials:NCT01615614]clinicaltrials:NCT01663168A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc [clinicaltrials:NCT01894776]clinicaltrials:NCT02099240Drug-drug Interaction (DDI) Rifabutin [clinicaltrials:NCT02138084]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Rifabutin [clinicaltrials_resource:0873c60740b3276b384569eae4aec237]
Bio2RDF identifier
0873c60740b3276b384569eae4aec237
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0873c60740b3276b384569eae4aec237
identifier
clinicaltrials_resource:0873c60740b3276b384569eae4aec237
title
Rifabutin
@en
type
label
Rifabutin [clinicaltrials_resource:0873c60740b3276b384569eae4aec237]
@en